Dissecting underlying mechanisms of aging
Aging is not a disease, but it is often accompanied by a complex array of chronic degenerative diseases. Sironax is committed to promoting healthier aging by targeting the underlying mechanisms of degeneration across various organs and tissues, including neuronal/axonal degeneration, muscle degeneration, epithelial cell death, neuroinflammation, and oxidative stress.
Explore our pipeline
A robust pipeline of first-in-class and best-in-class assets, including multiple clinical-stage small molecule programs and large molecule therapeutics enabled by our proprietary Brain Delivery Module (BDM) platform.
Company News
July. 10, 2025
Comments from Dr. Shefali Agarwal, President and CEO, on Agreement with Novartis
July. 09, 2025
Sironax Grants Novartis Exclusive Option to Acquire its Brain Delivery Platform While Retaining Rights to Advance Selected Therapeutic Assets